Venetoclax (Ventok) 10/50/100mg Tablets | BCL-2 Inhibitor Generic for CLL/SLL & AML | GLT

Generic Information: Ventok (Venetoclax)

Ventok is a generic formulation of venetoclax, the world's first-in-class, orally bioavailable, selective inhibitor of the B-cell lymphoma-2 (BCL-2) protein. Venetoclax restores programmed cell death (apoptosis) in malignant cells and has become a cornerstone of treatment for chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL) and acute myeloid leukemia (AML). Ventok is manufactured by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd (Laos) under GMP-certified conditions and supplied worldwide by GIVE LIFE TIME LIMITED (GLT).

What Is Ventok (Venetoclax) Used For?

Ventok (venetoclax) is used for the treatment of adult patients with:

• Chronic lymphocytic leukemia (CLL) — as fixed-duration therapy in combination regimens (e.g., with obinutuzumab or rituximab) or as monotherapy in relapsed/refractory disease, including 17p deletion / TP53-mutated CLL.
• Small lymphocytic lymphoma (SLL).
• Acute myeloid leukemia (AML) — in combination with azacitidine or low-dose cytarabine for newly diagnosed AML in patients ineligible for intensive induction chemotherapy.

In pivotal studies of originator venetoclax, fixed-duration combinations delivered superior progression-free survival and high rates of undetectable minimal residual disease (MRD) in CLL, and in AML venetoclax plus azacitidine achieved a complete response rate of 66.4% with median overall survival of 14.7 months in unfit patients.

How Does Ventok (Venetoclax) Work?

Venetoclax selectively binds the anti-apoptotic BCL-2 protein that CLL cells and AML blasts rely on for survival. By displacing pro-apoptotic proteins such as BIM from BCL-2, it re-activates the apoptotic pathway, and the malignant cell self-destructs. This targeted mechanism delivers deep remissions with a manageable safety profile — and the generic formulation offers the same active molecule at a fraction of the originator price.

Indications

• Chronic lymphocytic leukemia (CLL) — combination or monotherapy
• Small lymphocytic lymphoma (SLL)
• Acute myeloid leukemia (AML) — combination therapy in unfit patients
• Active in high-risk 17p deletion / TP53-mutated disease

Dosage & Administration

Available strengths: 10mg × 14's; 50mg × 21's; 100mg × 112's.

For CLL, venetoclax is initiated with a 5-week once-daily ramp-up (20 mg → 50 mg → 100 mg → 200 mg → 400 mg) with mandatory tumor lysis syndrome (TLS) prophylaxis, hydration and laboratory monitoring, then continues at 400 mg once daily. For AML in combination with azacitidine, ramp up 100 mg → 200 mg → 400 mg over cycle 1 days 1–3, then 400 mg daily. Tablets are taken orally with food and water, swallowed whole, at the same time each day. Treatment must be initiated and supervised by an experienced hematologist/oncologist.

Side Effects

The most clinically important risk is tumor lysis syndrome (TLS) during initiation in high-tumour-burden patients. Common adverse reactions include neutropenia (with infection risk), diarrhoea, nausea, anaemia, thrombocytopenia, fatigue and cough. Strong CYP3A4 inhibitors/inducers require dose adjustment or avoidance. Venetoclax can cause fetal harm; effective contraception is required during and after treatment.

Storage

Store Ventok tablets at controlled room temperature (20–25 °C) in the original packaging, protected from moisture. Keep out of reach of children. Ambient (non-cold-chain) shipping is suitable for oral tablets.

Why Choose the GLT?

• Authentic, GMP-certified sourcing — Tongmeng (Lao) Pharmaceutical and Food Co., Ltd manufactures Ventok under GMP conditions with full batch documentation (CoA and batch traceability).
• Affordable access — generic venetoclax offers a significantly lower cost per cycle than originator Venclexta/Venclyxto.
• Same mechanism, same molecule — first-in-class BCL-2 inhibition delivering deep, MRD-negative remissions in CLL/SLL and AML.
• Oral home-based treatment — fixed-duration tablet therapy, no infusion required.
• Reliable supply by GLT — GIVE LIFE TIME LIMITED (Hong Kong) ships worldwide with CoA, CPP and batch traceability.

How to Order Ventok (Venetoclax) from GLT?

1. Contact us via WhatsApp +86 15234153837 or email [email protected] with the product name, specification and quantity.
2. Receive a formal quotation, payment instructions and estimated delivery time.
3. Complete payment via our secure payment channel (Hao Yi Lian / 好易联).
4. Goods are dispatched with batch documentation; tracking provided until delivery.

We serve both licensed institutions (hospital procurement, pharmacies, importers) and individual patients. A valid prescription may be requested before dispatch.

FAQ

1. What strengths of Ventok are available?

Ventok is available as 10mg × 14's; 50mg × 21's; 100mg × 112's film-coated tablets. CLL therapy uses a 5-week ramp-up to the 400 mg daily target dose; AML combination therapy ramps to 400 mg daily.

2. Is generic venetoclax as effective as Venclexta?

Generic venetoclax contains the same active molecule at the same strength. Ventok is manufactured under GMP-certified conditions, offering the same mechanism of action at a much lower cost.

3. Why is the ramp-up schedule so important?

The gradual 5-week dose ramp-up, hydration and lab monitoring keep tumor lysis syndrome (TLS) risk manageable during initiation and are mandatory safety measures.

4. How is Ventok shipped internationally?

As an oral tablet, Ventok ships via ambient temperature-controlled courier with full batch documentation. Typical delivery is 7–14 days depending on destination.

5. Can I order Ventok for personal use?

GLT serves both institutions and individual patients. Individual buyers should hold a valid prescription and use this medicine under hematologist/oncologist supervision.